VAR - Varian Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
128.07
+0.87 (+0.68%)
At close: 4:02PM EDT

128.07 0.00 (0.00%)
After hours: 4:53PM EDT

Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close127.20
Open127.83
Bid127.91 x 800
Ask128.53 x 1100
Day's Range127.16 - 129.36
52 Week Range101.42 - 142.50
Volume449,464
Avg. Volume608,020
Market Cap11.647B
Beta (3Y Monthly)0.89
PE Ratio (TTM)31.12
EPS (TTM)4.12
Earnings DateJul 23, 2019 - Jul 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1998-12-02
1y Target Est149.29
  • American City Business Journals10 hours ago

    Roundup for this week's deals and dollars | May 24, 2019

    Here's a look at some of the deals and dollars involving North Texas companies and firms this week.

  • Why Is Varian (VAR) Down 4.9% Since Last Earnings Report?
    Zacks10 hours ago

    Why Is Varian (VAR) Down 4.9% Since Last Earnings Report?

    Varian (VAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Thomson Reuters StreetEvents2 days ago

    Edited Transcript of VAR earnings conference call or presentation 24-Apr-19 8:30pm GMT

    Q2 2019 Varian Medical Systems Inc Earnings Call

  • Stock Market News For May 21, 2019
    Zacks3 days ago

    Stock Market News For May 21, 2019

    Wall Street closed in the red on Monday as blacklisting of the Chinese tech behemoth Huawei by the U.S. government hit technology stocks.

  • Varian Medical's CTSI Buyout to Boost Oncology Services Unit
    Zacks3 days ago

    Varian Medical's CTSI Buyout to Boost Oncology Services Unit

    The CTSI buyout is expected to prove accretive to Varian Medical's (VAR) adjusted earnings per share during fiscal 2021.

  • Benzinga3 days ago

    The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 20) Kaleido Biosciences Inc (NASDAQ: KLDO ) Down In The ...

  • PR Newswire4 days ago

    Varian Announces Definitive Agreement to Acquire Cancer Treatment Services International

    PALO ALTO, Calif., May 20, 2019 /PRNewswire/ -- Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems (VAR) today announced it has entered into a definitive agreement to acquire Cancer Treatment Services International (CTSI) for $283 million. Privately held, CTSI operates the American Oncology Institute in Hyderabad and 10 multidisciplinary—radiation, medical and surgical oncology— cancer centers across the Indian subcontinent as well as a U.S.-based Oncology Solutions division that provides cancer care professional services to healthcare providers worldwide.

  • Varian Medical Installs ProBeam at Research Hub in Singapore
    Zacks7 days ago

    Varian Medical Installs ProBeam at Research Hub in Singapore

    Varian Medical's (VAR) APAC revenues grow 7% year over year in the fiscal second quarter.

  • PR Newswire8 days ago

    Varian Announces Incremental Gross Impact of New Tariffs

    PALO ALTO, Calif., May 16, 2019 /PRNewswire/ -- Varian (VAR) today announced preliminary estimates of the incremental gross impact of new tariffs. Over the past week, the US increased tariffs on certain goods (US List 3), and imposed new tariffs on certain other goods (US List 4), imported from China.  Subsequently, China implemented a retaliatory increase in tariffs on certain goods imported from the US (responding to the US List 3 action).  Management has preliminarily estimated the gross impact of these new tariffs to be in the range of $3M to $5M.

  • PR Newswire11 days ago

    Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore

    The cyclotron is a core piece of equipment in the ProBeam proton therapy system. This installation marks a key milestone for the first proton therapy center in Singapore, ASEAN, Australia and New Zealand.

  • PR Newswire11 days ago

    Papua New Guinea Hospital Selects Varian Cancer Care Solution

    PALO ALTO, Calif., May 13, 2019 /PRNewswire/ -- Varian (VAR) today announced it was selected by Port Moresby General Hospital (PMGH) in Papua New Guinea to equip its cancer treatment center with the Halcyon™ radiotherapy system, as well as the ARIA® oncology information system and Eclipse™ treatment planning system. The Halcyon system simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient comfort and shortening the time from installation to first-treatment without sacrificing quality. The Halcyon system is well-suited to treat a majority of cancer patients, offering advanced treatments for lung, prostate, breast, head & neck, and many other forms of cancer.

  • PR Newswire15 days ago

    Varian Acquires CyberHeart

    The CyberHeart acquisition secures significant intellectual property/patents that cover the use of radiation in the heart. Early positive clinical evidence suggests that cardiac radioablation has the potential to offer hope to patients with intractable cardiac arrhythmias. Acquisitions are a critical step in Varian's long-term strategy to become a global leader in multi-disciplinary, integrated cancer solutions as well as other applications of radiation medicine.

  • PR Newswire16 days ago

    Varian Selected to Equip Two Proton Therapy Centers in Norway

    PALO ALTO, Calif. , May 9, 2019 /PRNewswire/ -- Following a comprehensive evaluation by Sykehusbygg HF Norway and regional health authorities, Varian (NYSE: VAR) was selected to equip two proton therapy ...

  • PR Newswire16 days ago

    Varian and Shandong Cancer Hospital Form Proton Therapy Clinical Application and Research Partnership in China

    PALO ALTO, Calif. and JINAN, China, May 9, 2019 /PRNewswire/ -- Varian (VAR) today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton therapy clinical application and research. The agreement signing ceremony on May 9th in Jinan, China was attended by Professor Yu Jinming, academician of the Chinese Academy of Engineering and president of Shandong Cancer Hospital & Institute, Kolleen Kennedy, president, Proton Solutions and chief growth officer of Varian, and Dr. Zhang Xiao, vice president and head of Varian Greater China.

  • PR Newswire17 days ago

    Varian to Attend Upcoming Investor Events

    PALO ALTO, Calif. , May 7, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will be attending the UBS Global Healthcare Conference ( May 20-22 ) and the 2019 RBC Capital Markets Healthcare ...

  • Markit17 days ago

    See what the IHS Markit Score report has to say about Varian Medical Systems Inc.

    Varian Medical Systems Inc NYSE:VARView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for VAR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting VAR. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $790 million over the last one-month into ETFs that hold VAR are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Will Varian Medical Systems, Inc.'s (NYSE:VAR) Earnings Grow In The Next 12 Months?
    Simply Wall St.18 days ago

    Will Varian Medical Systems, Inc.'s (NYSE:VAR) Earnings Grow In The Next 12 Months?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! As Varian Medical Systems, Inc. (NYSE:VAR) announced its earnings release on 29 March 2019...

  • Varian's (VAR) Halcyon to Treat Patients at Japan's Hospital
    Zacks23 days ago

    Varian's (VAR) Halcyon to Treat Patients at Japan's Hospital

    Varian's (VAR) Halcyon sees encouraging developments in recent times.

  • PR Newswire25 days ago

    South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System

    PALO ALTO, Calif. and CAPE TOWN, South Africa, April 30, 2019 /PRNewswire/ -- Varian (VAR) announced Groote Schuur Hospital in Cape Town, South Africa is the first hospital in Africa to deliver High Dose Rate (HDR) brachytherapy treatments with the Bravos™ afterloader system. Bravos is an integrated system designed to improve the patient and clinic experience by simplifying brachytherapy treatments and providing greater workflow efficiency. HDR brachytherapy involves delivering radiotherapy by temporarily placing a tiny radioactive source directly into the tumor or other targeted area.

  • PR Newswire25 days ago

    Ofuna Chuo Hospital Delivers First Varian Halcyon System Treatments in Japan

    PALO ALTO, Calif., April 29, 2019 /PRNewswire/ -- Varian (VAR) today announced Ofuna Chuo Hospital, Kamakura City, Kanagawa Prefecture, Japan is the first clinic in the country to begin treating cancer patients using the Halcyon™ radiotherapy system. The Halcyon system simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient comfort and shortening the time from installation to first-treatment without sacrificing quality.

  • PR Newswire29 days ago

    Varian Announces Global Clinical Consortium to Develop Evidence-based Protocols for Adaptive Radiotherapy

    PALO ALTO, Calif. , April 26, 2019 /PRNewswire/ -- Bringing together a global community of clinicians and scientists from leading cancer clinics to develop best practices for adaptive radiotherapy based ...

  • Varian (VAR) Q2 Earnings Lag Estimates, Gross Orders Surge
    Zacks29 days ago

    Varian (VAR) Q2 Earnings Lag Estimates, Gross Orders Surge

    Varian (VAR) gains from solid segmental contributions in Q2, raises revenue guidance.

  • Benzinga29 days ago

    The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings

    Here's a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stocks hit 52-week highs Wednesday. Down In The Dumps (Biotech stocks hitting 52-week lows on April ...

  • VARIAN MEDICAL SYSTEMS INC (VAR) Q2 2019 Earnings Call Transcript
    Motley Foollast month

    VARIAN MEDICAL SYSTEMS INC (VAR) Q2 2019 Earnings Call Transcript

    VAR earnings call for the period ending March 29, 2019.